» Articles » PMID: 35003358

Linc01513 Inhibits the Malignant Potential of Nasopharyngeal Carcinoma by Binding to PTBP1

Overview
Journal J Cancer
Specialty Oncology
Date 2022 Jan 10
PMID 35003358
Authors
Affiliations
Soon will be listed here.
Abstract

LncRNAs are reported to be involved in tumor proliferation, invasion and metastasis, and are considered as potential biomarkers and therapeutic targets for human cancer, including head and neck cancer. In this study, we screened the differentially low-expressed linc01513 by bioinformatic to detect its expression and biological effect on nasopharyngeal carcinoma (NPC). MTT was used to evaluate the effect of linc01513 on the proliferation of NPC cells. Wound healing assay was used to determine the cells migration ability. The matrix transwell was used to further detect the role of linc01513 in cell invasion. Western blot was used to detect the expression of epithelial-mesenchymal transformation (EMT)-induced transcription factors E-cadherin, vimentin and Slug. The results showed that silence of linc01513 could promoted the proliferation, migration and invasion of NPC cells. The experiment showed that overexpression of linc01513 could inhibit the volume and weight of xenograft tumors. Database prediction, RNA pull-down and RIP experiments suggested that linc01513 may play an anti-tumor effect by inhibiting PTBP1 protein level. It is suggested that linc01513 directly binds to PTBP1 protein and mediates the EMT process and malignant biological behavior of NPC cells, which provides a new molecular marker for the prognosis and treatment of NPC.

Citing Articles

Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.

You X, Wu Y, Li Q, Sheng W, Zhou Q, Fu W Front Pharmacol. 2022; 13:895696.

PMID: 35847007 PMC: 9277392. DOI: 10.3389/fphar.2022.895696.


Long non-coding RNA RGMB-AS1 represses nasopharyngeal carcinoma progression via binding to forkhead box A1.

Zhang T, Jin Y, Luo X Bioengineered. 2022; 13(3):5564-5580.

PMID: 35184697 PMC: 8973592. DOI: 10.1080/21655979.2022.2039495.

References
1.
Xu Y, Yao Y, Qin W, Zhong X, Jiang X, Cui Y . Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Biomed Pharmacother. 2018; 99:121-127. DOI: 10.1016/j.biopha.2018.01.061. View

2.
Le Q, Colevas A, OSullivan B, Lee A, Lee N, Ma B . Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy. J Natl Cancer Inst. 2019; 111(7):655-663. PMC: 7962891. DOI: 10.1093/jnci/djz044. View

3.
Zhou L, Liu R, Liang X, Zhang S, Bi W, Yang M . lncRNA RP11-624L4.1 Is Associated with Unfavorable Prognosis and Promotes Proliferation via the CDK4/6-Cyclin D1-Rb-E2F1 Pathway in NPC. Mol Ther Nucleic Acids. 2020; 22:1025-1039. PMC: 7558227. DOI: 10.1016/j.omtn.2020.10.017. View

4.
Fang M, Zhang M, Wang Y, Wei F, Wu J, Mou X . Long Noncoding RNA AFAP1-AS1 Is a Critical Regulator of Nasopharyngeal Carcinoma Tumorigenicity. Front Oncol. 2020; 10:601055. PMC: 7719841. DOI: 10.3389/fonc.2020.601055. View

5.
Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y . Long non-coding RNA: a new player in cancer. J Hematol Oncol. 2013; 6:37. PMC: 3693878. DOI: 10.1186/1756-8722-6-37. View